News Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston Staff September 11, 2023 Post Navigation Previous Major shareholder announcement – BlackRock, Inc.Next Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration More Stories Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 EHR Healthcare News Patient Care Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships Staff December 23, 2024
